Shock Wave Therapy Promotes Cardiomyocyte Autophagy and Survival during Hypoxia

Cellular Physiology and Biochemistry

Volumn 42, Issue 2, 2017, Pages 673-684

  Du, Ling ^a,b   Shen, Tao ^c   Liu, Bing ^b   Zhang, Yunhe ^b   Zhao, Cong ^b   Jia, Na ^b   Wang, Que ^c   He, Qing ^a,b,c  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b Department of Cardiology ^*  (China)

^c BEIJING HOSPITAL   (China)

Author keywords

AMPK mTOR; Autophagy; Ischemia hypoxia; Shock wave

Indexed keywords

ADENOSINE TRIPHOSPHATE; BECLIN 1; DANSYLCADAVERINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 1; SIRTUIN 1;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CARDIAC MUSCLE CELL; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHOCK WAVE THERAPY; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL HYPOXIA; CELL LINE; DISEASE MODEL; GENETICS; HIGH-ENERGY SHOCK WAVE; HUMAN; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PHAGOSOME; PHOSPHORYLATION; RADIATION RESPONSE; THERAPEUTIC USE;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; HIGH-ENERGY SHOCK WAVES; HUMANS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PHAGOSOMES; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION;

EID: 85024404859     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000477885     Document Type: Article

References (39)

1. Jolicoeur EM, Ohman EM, Temple R, Stockbridge N, Smith S, Mark D, Califf RM, Henry TD, Chaitman BR, Granger CB: Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues. Am Heart J 2008; 155: 435-444.
2. Henry TD, Satran D, Hodges JS, Johnson RK, Poulose AK, Campbell AR, Garberich RF, Bart BA, Olson RE, Boisjolie CR, Harvey KL, Arndt TL, Traverse JH: Long-term survival in patients with refractory angina. Eur Heart J 2013; 34: 2683-2688.
3. Mariotto S, de Prati AC, Cavalieri E, Amelio E, Marlinghaus E, Suzuki H: Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Curr Med Chem 2009; 16: 2366-2372.
4. Abe Y, Ito K, Hao K, Shindo T, Ogata T, Kagaya Y, Kurosawa R, Nishimiya K, Satoh K, Miyata S, Kawakami K, Shimokawa H: Extracorporeal low-energy shock-wave therapy exerts anti-inflammatory effects in a rat model of acute myocardial infarction. Circ J 2014; 78: 2915-2925.
5. Fu M, Sun CK, Lin YC, Wang CJ, Wu CJ, Ko SF, Chua S, Sheu JJ, Chiang CH, Shao PL, Leu S, Yip HK: Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment. PLoS One 2011; 6:e24342.
6. Lei PP, Tao SM, Shuai Q, Bao YX, Wang SW, Qu YQ, Wang DH: Extracorporeal cardiac shock wave therapy ameliorates myocardial fibrosis by decreasing the amount of fibrocytes after acute myocardial infarction in pigs. Coron Artery Dis 2013; 24: 509-515.
7. Wang J, Zhou C, Liu L, Pan X, Guo T: Clinical effect of cardiac shock wave therapy on patients with ischaemic heart disease: a systematic review and meta-analysis. Eur J Clin Invest 2015; 45: 1270-1285.
8. Liu B, Chen C, Zhang R, Li W, Yao Z, He Q: Clinical study on treatment of extracorporeal cardiac shock wave therapy in refractory angina pectoris patients. Chin J Cardiovasc Med 2015; 20: 23-28.
9. Aicher A, Heeschen C, Sasaki K, Urbich C, Zeiher AM, Dimmeler S: Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006; 114: 2823-2830.
10. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, Yasui H, Takeshita A, Sunagawa K: Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004; 110: 3055-3061.
11. Yu W, Shen T, Liu B, Wang S, Li J, Dai D, Cai J, He Q: Cardiac shock wave therapy attenuates H9c2 myoblast apoptosis by activating the AKT signal pathway. Cell Physiol Biochem 2014; 33: 1293-1303.
12. Murrow L, Debnath J: Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu Rev Pathol 2013; 8: 105-137.
13. Gottlieb RA, Mentzer RM: Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010; 72: 45-59.
14. Schiattarella GG, Hill JA: Therapeutic targeting of autophagy in cardiovascular disease. J Mol Cell Cardiol 2016; 95: 86-93.
15. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, Diwan A: Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 2012; 125: 3170-3181.
16. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J: Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-922.
17. Zhang J, He Z, Xiao W, Na Q, Wu T, Su K, Cui X: Overexpression of BAG3 Attenuates Hypoxia-Induced Cardiomyocyte Apoptosis by Inducing Autophagy. Cell Physiol Biochem 2016; 39: 491-500.
18. Biederbick A, Kern HF, Elsasser HP: Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 1995; 66: 3-14. 7750517
19. Egan D, Kim J, Shaw RJ, Guan KL: The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 2011; 7: 643-644.
20. Xiao J, Zhu X, Kang B, Xu J, Wu L, Hong J, Zhang Y, Ni X, Wang Z: Hydrogen Sulfide Attenuates Myocardial Hypoxia-Reoxygenation Injury by Inhibiting Autophagy via mTOR Activation. Cell Physiol Biochem 2015; 37: 2444-2453.
21. Takagi H, Matsui Y, Hirotani S, Sakoda H, Asano T, Sadoshima J: AMPK mediates autophagy during myocardial ischemia in vivo. Autophagy 2007; 3: 405-407.
22. Inoki K, Corradetti MN, Guan KL: Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37: 19-24.
23. Cao Y, Shen T, Huang X, Lin Y, Chen B, Pang J, Li G, Wang Q, Zohrabian S, Duan C, Ruan Y, Man Y, Wang S, Li J: Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Oncotarget 2017; 8: 4837-4848.
24. Meng X, Tan J, Li M, Song S, Miao Y, Zhang Q: Sirt1: Role Under the Condition of Ischemia/Hypoxia. Cell Mol Neurobiol 2017; 37: 17-28.
25. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G: Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991; 69: 1476-1486.
26. Zhao M, Sun L, Yu XJ, Miao Y, Liu JJ, Wang H, Ren J, Zang WJ: Acetylcholine mediates AMPK-dependent autophagic cytoprotection in H9c2 cells during hypoxia/reoxygenation injury. Cell Physiol Biochem 2013; 32: 601-613.
27. Huang Z, Han Z, Ye B, Dai Z, Shan P, Lu Z, Dai K, Wang C, Huang W: Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. Eur J Pharmacol 2015; 762: 1-10.
28. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Yang G, Matsui Y, Sadoshima J, Vatner SF: Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102: 13807-13812.
29. Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, Richardson JA, Le V, Levine B, Rothermel BA, Hill JA: Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007; 117: 1782-1793.
30. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J, Tabas I: Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab 2012; 15: 545-553.
31. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL: Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008; 283: 10892-10903.
32. Valentim L, Laurence KM, Townsend PA, Carroll CJ, Soond S, Scarabelli TM, Knight RA, Latchman DS, Stephanou A: Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol 2006; 40: 846-852.
33. Loos B, Genade S, Ellis B, Lochner A, Engelbrecht AM: At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Exp Cell Res 2011; 317: 1437-1453.
34. Ogden JA, Toth-Kischkat A, Schultheiss R: Principles of shock wave therapy. Clin Orthop Relat Res 2001; 8-17.
35. Lavandero S, Chiong M, Rothermel BA, Hill JA: Autophagy in cardiovascular biology. J Clin Invest 2015; 125: 55-64.
36. Zhang Y, Shen T, Liu B, Du L, Zhao C, He Q: Cardiac shock wave therapy Myocytes, cardiac Apoptosis Safety. Chin J Cardiovasc Med 2016; 21: 126-130.
37. Troncoso R, Vicencio JM, Parra V, Nemchenko A, Kawashima Y, Del Campo A, Toro B, Battiprolu PK, Aranguiz P, Chiong M, Yakar S, Gillette TG, Hill JA, Abel ED, Leroith D, Lavandero S: Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy. Cardiovasc Res 2012; 93: 320-329.
38. Yuan G, Nanduri J, Khan S, Semenza GL, Prabhakar NR: Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 2008; 217: 674-685.
39. Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW: Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 2010; 38: 864-878.